• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,084
2,275
1,819
1,803
1,709

COUNTRY

827
638
256
247
206

CATEGORIES

  • 856
  • 184
  • 950
  • 1,127
    • 99
  • 385
  • 270
  • 251
  • 65
  • 379
  • 673
  • 1,255
  • 1,621
  • 625
  • 883
  • 1,672
  • 2,632
    • 574
    • 118
    • 550
    • 75
    • 526
    • 43
    • 505
    • 18
    • 18
    • 23
  • 505
  • 727
  • 0
  • 97

PRICE

6,631
11,254
16,926
24,661

PUBLISHED

1,605
3,130
6,998
24,661

PRODUCT TYPE

20,289
3,174
856
164
74
44
21
21
11
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

Bone Marrow Transplantation - Pipeline Review, H2 2013

Bone Marrow Transplantation - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Bone Marrow Transplantation - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

July 2013
FROM

Estrace (Postmenopausal Vaginal Atrophy) - Forecast and Market Analysis to 2022

Estrace (Postmenopausal Vaginal Atrophy) - Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past decade,...

July 2013
FROM

Streptococcal Infections - Pipeline Review, H2 2013

Streptococcal Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Streptococcal Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

July 2013
FROM

Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H2 2013

Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H2 2013', provides an overview of...

July 2013
FROM

Peanut Allergy - Pipeline Review, H2 2013

Peanut Allergy - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Peanut Allergy - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

July 2013
FROM

Neurofibromatoses Type II - Pipeline Review, H2 2013

Neurofibromatoses Type II - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Neurofibromatoses Type II - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

July 2013
FROM

Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2013

Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline...

July 2013
FROM

Brain Tumor - Pipeline Review, H2 2013

Brain Tumor - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Brain Tumor - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

July 2013
FROM

Muscle Wasting Disorders - Pipeline Review, H2 2013

Muscle Wasting Disorders - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Muscle Wasting Disorders - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

July 2013
FROM

Psychosis - Pipeline Review, H2 2013

Psychosis - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Psychosis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

July 2013
FROM

Metastatic Colorectal Cancer - Pipeline Review, H2 2013

Metastatic Colorectal Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Metastatic Colorectal Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

July 2013
FROM

Toxic Shock - Pipeline Review, H2 2013

Toxic Shock - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Toxic Shock - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

July 2013
FROM

Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2013

'Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development for Opioid-Induced...

July 2013
FROM

Metastatic Pancreatic Cancer - Pipeline Review, H2 2013

Metastatic Pancreatic Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Metastatic Pancreatic Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

July 2013
FROM

Liver Cancer - Pipeline Review, H2 2013

Liver Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Liver Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

July 2013
FROM

Botulism - Pipeline Review, H2 2013

Botulism - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Botulism - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

July 2013
FROM

Lithuania Pharmaceuticals and Healthcare Report Q3 2013

BMI View: Unfavourable economic headwinds will continue to pose downside risks to our pharmaceutical market forecasts for the Lithuanian market, especially given that out-of-pocket payments continue...

July 2013

Puerto Rico Pharmaceuticals and Healthcare Report Q3 2013

BMI View: The loss of confidence in the key pharmaceutical sector is expected to impact consumption levels directly. The fate of the Puerto Rican pharmaceutical market will also remain closely tied...

July 2013

Romania Pharmaceuticals and Healthcare Report Q3 2013

BMI View: We forecast continued growth in Romania's pharmaceutical market due to greater private contributions to the cost of healthcare and a return to slight economic growth in 2013. The partial removal...

July 2013

Zimbabwe Pharmaceuticals and Healthcare Report Q3 2013

BMI View: We do not expect any improvements in the way of the operating environment for pharmaceutical industry players in Zimbabwe, especially as the political situation remains tense in the runup...

July 2013
Loading Indicator

Our Clients

Our clients' logos